Journal Club (issue 7): Telmisartan for proteinuria and renal disease
This journal club covers 2 open access papers on the use of Telmisartan to lower urine protein creatinine ratio in chronic kidney disease. One of these was published at the end of 2020 cpmaring its use to Enalipril in dogs, and another back in 2015 comparing its use to Benzapril in cats. We go through the pharmacology of Telmisartan and the theoretical advantages of an angiotensin II receptor inhibitor over an angiotensin converting enzyme (ACE) inhibitor. We cover how these studies were performed and how they add to the current literature and may change the way we treat cases of Chronic kidney disease with elevated UPCs.
Meet the speakers
Director, Cardiology Specialist
already purchased this webinar? login to your vtx account for accesslogin